FDA Brief

Company record

Diagnostica Stago, Inc.

0 FDA warning letters since 2023 and 4 recalls in the last 12 months.

Get an email the day FDA posts anything new about Diagnostica Stago, Inc..

Recalls

ReportedClassFirmProduct and reason
Sep 9 Class II Diagnostica Stago, Inc.
Device
STA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitative factor deficiency test
A positive drift in QC values within the reagent's stated 4-hour onboard stability period was identified
Mar 25 Class II Diagnostica Stago, Inc.
Device
Brand Name: STA Liatest D-Di Product Name: STA Liatest D-Di Model/Catalog Number: REF 00515 Product Description: in vitro diagnostic. The STA - Liatest D-Di kit is an assay for the quantitative determination of D-dime…
After receiving customer complaints, investigations confirmed the presence of a positive bias in D-Dimer measurements throughout the entire analytical range.
Mar 11 Class II Diagnostica Stago, Inc.
Device
Brand Name: STA Liatest Free Protein S Product Name: STA Liatest Free Protein S Model/Catalog Number (REF): 00516 Product Description: The STA¿ - Liatest¿ Free Protein S kits are intended for use on STA-R¿ and STA Com…
The potential of out-of-range results and an underestimation of the free protein S level in normal patient plasmas. The defect only affects normal-range values.
Jan 21 Class II Diagnostica Stago, Inc.
Device
Asserachrom HPIA. Model/Catalog Number: 00615. The Asserachrom HPIA kit is intended for the qualitative detection in plasma or serum of the anti-heparin-platelet factor 4 (PF4) antibodies generated during the type I…
Potential for defect for Asserachrom HPIA lot 271288, which can affect every well in the impacted strip and produce negative results.